Terms: = Prostate cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Prognosis
313 results:
1. Interference with mitochondrial metabolism could serve as a potential therapeutic strategy for advanced prostate cancer.
Wu C; Zhu H; Zhang Y; Ding L; Wang J
PLoS One; 2024; 19(4):e0290753. PubMed ID: 38598542
[TBL] [Abstract] [Full Text] [Related]
2. Identification of Genes with Rare Loss of Function Variants Associated with Aggressive prostate cancer and Survival.
Saunders EJ; Dadaev T; Brook MN; Wakerell S; Govindasami K; Rageevakumar R; Hussain N; Osborne A; Keating D; Lophatananon A; Muir KR; ; Darst BF; Conti DV; Haiman CA; Antoniou AC; Eeles RA; Kote-Jarai Z
Eur Urol Oncol; 2024 Apr; 7(2):248-257. PubMed ID: 38458890
[TBL] [Abstract] [Full Text] [Related]
3. Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database.
Guo L; Liu L; Liu Y; Yang T; Wang G; Liu J; Li S; Cai J
BMJ Open; 2024 Mar; 14(3):e080092. PubMed ID: 38458812
[TBL] [Abstract] [Full Text] [Related]
4. Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning.
Kang Z; Zhao YX; Qiu RSQ; Chen DN; Zheng QS; Xue XY; Xu N; Wei Y
Cancer Immunol Immunother; 2024 Feb; 73(3):41. PubMed ID: 38349474
[TBL] [Abstract] [Full Text] [Related]
5. PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.
Yang T; Chi Y; Wang X; Xu C; Chen X; Liu Y; Huang S; Zhu X; Zhang H; Zhuo H; Wu D
Cell Death Dis; 2024 Feb; 15(2):128. PubMed ID: 38341429
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a basement membrane gene signature for predicting prognosis and estimating the tumor immune microenvironment in prostate cancer.
Xie T; Fu DJ; Li KJ; Guo JD; Xiao ZM; Li Z; Zhao SC
Aging (Albany NY); 2024 Jan; 16(2):1581-1604. PubMed ID: 38240702
[TBL] [Abstract] [Full Text] [Related]
7. Tumor-associated macrophages and PD-L1 in prostate cancer: a possible key to unlocking immunotherapy efficacy.
Wang J; Wu W; Yuan T; Wang L; Zang L; Liu Q; Wang L; Huo X; Huo B; Tang Y; Wang H; Zhao Z
Aging (Albany NY); 2024 Jan; 16(1):445-465. PubMed ID: 38189834
[TBL] [Abstract] [Full Text] [Related]
8. Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer.
Lai C; Wu Z; Li Z; Huang X; Hu Z; Yu H; Yuan Z; Shi J; Hu J; Mulati Y; Liu C; Xu K
Clin Transl Oncol; 2024 May; 26(5):1240-1255. PubMed ID: 38070051
[TBL] [Abstract] [Full Text] [Related]
9. CAV1 and KRT5 are potential targets for prostate cancer.
Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
[TBL] [Abstract] [Full Text] [Related]
10. Association of WHSC1/NSD2 and T-cell infiltration with prostate cancer metastasis and prognosis.
Li Q; Zhu J; Zhang Y; Pan Y; Li Z; Wang M; Gao Y; Feng D; He X; Zhang C
Sci Rep; 2023 Dec; 13(1):21629. PubMed ID: 38062230
[TBL] [Abstract] [Full Text] [Related]
11. A novel tumor purity and immune infiltration-related model for predicting distant metastasis-free survival in prostate cancer.
Su Q; Zhu Y; He B; Dai B; Mu W; Tian J
Eur J Med Res; 2023 Nov; 28(1):545. PubMed ID: 38017548
[TBL] [Abstract] [Full Text] [Related]
12. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
13. Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Ozyerli-Goknar E; Kala EY; Aksu AC; Bulut I; Cingöz A; Nizamuddin S; Biniossek M; Seker-Polat F; Morova T; Aztekin C; Kung SHY; Syed H; Tuncbag N; Gönen M; Philpott M; Cribbs AP; Acilan C; Lack NA; Onder TT; Timmers HTM; Bagci-Onder T
Cell Commun Signal; 2023 Nov; 21(1):328. PubMed ID: 37974198
[TBL] [Abstract] [Full Text] [Related]
14. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.
Zhu W; Zeng H; Huang J; Wu J; Wang Y; Wang Z; Wang H; Luo Y; Lai W
J Transl Med; 2023 Nov; 21(1):782. PubMed ID: 37925432
[TBL] [Abstract] [Full Text] [Related]
15. setD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest.
Wang C; Wang T; Li KJ; Hu LH; Li Y; Yu YZ; Xie T; Zhu S; Fu DJ; Wang Y; Zeng XZ; Liu FP; Chen H; Chen ZS; Feng NH; Liu J; Jiang Y; Zhao SC
Cancer Lett; 2023 Nov; 579():216464. PubMed ID: 37879429
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.
Zhang Z; Cai Q; Wang J; Yao Z; Ji F; Hang Y; Ma J; Jiang H; Yan B; Zhanghuang C
Sci Rep; 2023 Oct; 13(1):17719. PubMed ID: 37853026
[TBL] [Abstract] [Full Text] [Related]
17. Integrated transcriptome and proteome analysis indicates potential biomarkers of prostate cancer in offspring of pregnant rats exposed to a phthalate mixture during gestation and lactation.
Aquino AM; Alonso-Costa LG; Santos SAA; Rocha VA; Barbisan LF; Bedrat A; Justulin LA; Flaws JA; Lemos B; Scarano WR
Chemosphere; 2023 Nov; 341():140020. PubMed ID: 37690569
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Prior cancer on the prognosis of Patients with Chondrosarcoma: A Population-Based Study of the SEER Database.
Qian J; Dai S; Wang H
Altern Ther Health Med; 2023 Nov; 29(8):674-679. PubMed ID: 37678875
[TBL] [Abstract] [Full Text] [Related]
19. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
Liu W; Wang M; Wang M; Liu M
Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
[TBL] [Abstract] [Full Text] [Related]
20. Coordinating single-cell and bulk RNA-seq in deciphering the intratumoral immune landscape and prognostic stratification of prostate cancer patients.
Sun Z; Wang J; Zhang Q; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Liu Y; Ye F; Ma B
Environ Toxicol; 2024 Feb; 39(2):657-668. PubMed ID: 37565774
[TBL] [Abstract] [Full Text] [Related]
[Next]
